These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2151622)

  • 21. [Molecular markers having a prognostic or therapeutic value in cancer].
    Brousset P
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibronectin, the generation of multiple polypeptides from a single gene.
    Owens RJ; Kornblihtt AR; Baralle FE
    Oxf Surv Eukaryot Genes; 1986; 3():141-60. PubMed ID: 3334363
    [No Abstract]   [Full Text] [Related]  

  • 23. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cellular biology of human cancers as a basis for seeking tumor markers].
    Klöppel G
    Verh Dtsch Ges Inn Med; 1991; 97():403-5. PubMed ID: 1808922
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of fibronectin in adhesion, migration, and metastasis.
    Humphries MJ; Obara M; Olden K; Yamada KM
    Cancer Invest; 1989; 7(4):373-93. PubMed ID: 2531625
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
    Shibata K; Kikkawa F; Nawa A; Suganuma N; Hamaguchi M
    Cancer Res; 1997 Dec; 57(23):5416-20. PubMed ID: 9393769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody to human osteosarcoma: a novel Mr 26,000 protein recognized by murine hybridoma TMMR-2.
    Tsai CC; McGuire MH; Mellitt RJ; Ritter RA; Xu JZ; Litwicki DJ; Roodman ST
    Cancer Res; 1990 Jan; 50(1):152-8. PubMed ID: 2293550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning, cDNA analysis, and localization of a monomer of the N-acetylglucosamine-specific receptor of the thyroid, NAGR1, to chromosome 19p13.3-13.2.
    Blanck O; Perrin C; Mziaut H; Darbon H; Mattei MG; Miquelis R
    Genomics; 1994 May; 21(1):18-26. PubMed ID: 8088785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thirty years after fibronectin discovery: role in malignant transformation and in ageing].
    Labat-Robert J
    J Soc Biol; 2004; 198(3):287-91. PubMed ID: 15662946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cell adhesion and the receptor family].
    Suzuki S
    Tanpakushitsu Kakusan Koso; 1987 Oct; 32(11):1305-20. PubMed ID: 2962231
    [No Abstract]   [Full Text] [Related]  

  • 31. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
    Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
    APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibronectin in cell, developmental, and neural biology].
    Hayashi M
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1964-80. PubMed ID: 6241962
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evolution of cancer markers: from radio-immunology to DNA chips and from surveillance to forecasting].
    Bellet D; Lazar V; de Paillerets BB; Bennaceur-Griscelli A; Bénard J; Bidart JM
    Bull Cancer; 2000 Jan; 87(1):35-9. PubMed ID: 10673630
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of monoclonal antibodies in the evaluation of the aggressiveness of tumors of the bladder].
    Ravery V; Popov Z; Bellot J; Abbou CC; Chopin DK
    Ann Urol (Paris); 1993; 27(1):45-50. PubMed ID: 8470880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis.
    Taverna D; Ullman-Culleré M; Rayburn H; Bronson RT; Hynes RO
    Cancer Res; 1998 Feb; 58(4):848-53. PubMed ID: 9485045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of a major cell-substratum adhesion system in cell behavior and morphogenesis.
    Dufour S; Duband JL; Thiéry JP
    Biol Cell; 1986; 58(1):1-13. PubMed ID: 2952199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibronectin.
    Akiyama SK; Yamada KM
    Adv Enzymol Relat Areas Mol Biol; 1987; 59():1-57. PubMed ID: 2949539
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor invasion and metastases: biochemical mechanisms.
    Liotta LA; Stracke ML
    Cancer Treat Res; 1988; 40():223-38. PubMed ID: 2908652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.